Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.
7(th) International Immunoglobulin Conference: Interlaken Leadership Awards.
Multiple sclerosis; a disease of reproductive-aged women and the dilemma involving contraceptive methods.
Restless leg syndrome and multiple sclerosis: a case-control study in China.
Podoplanin negatively regulates CD4+ effector T cell responses.
Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
The role of clinical and instrumented outcome measures in balance control of individuals with multiple sclerosis.
A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.
The search for responsive clinical endpoints in primary progressive multiple sclerosis.
Association between multiple sclerosis risk-associated SNPs and relapse and disability - a prospective cohort study.
Heterogeneity of root and nerve ultrasound pattern in CIDP patients.
Factors affecting employment among informal caregivers assisting people with multiple sclerosis.
Successful treatment of paroxysmal tonic spasms with topiramate in a patient with neuromyelitis optica.
Brain tissue segmentation using fuzzy clustering techniques.
Modulation of the Left Prefrontal Cortex with High Frequency Repetitive Transcranial Magnetic Stimulation Facilitates Gait in Multiple Sclerosis.
Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up.
Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - YES.
Antiretrovirals inhibit arginase in human microglia.
Upper Limb Rehabilitation in People With Multiple Sclerosis: A Systematic Review.
Mesenchymal stem cells of dental origin - their potential for anti-inflammatory and regenerative actions in brain and gut damage.
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.
Altered terminal Schwann cell morphology precedes denervation in SOD1 mice.
Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
Bromodomains: translating the words of lysine acetylation into myelin injury and repair.
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
Pages
« first
‹ previous
…
618
619
620
621
622
623
624
625
626
…
next ›
last »